Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 18 studies | 26% ± 8% | |
endothelial cell | 17 studies | 26% ± 9% | |
natural killer cell | 15 studies | 22% ± 6% | |
pericyte | 14 studies | 34% ± 13% | |
myofibroblast cell | 10 studies | 35% ± 10% | |
CD16-positive, CD56-dim natural killer cell, human | 8 studies | 23% ± 5% | |
mature NK T cell | 7 studies | 20% ± 4% | |
platelet | 7 studies | 20% ± 3% | |
CD8-positive, alpha-beta T cell | 7 studies | 22% ± 5% | |
CD8-positive, alpha-beta memory T cell | 7 studies | 20% ± 3% | |
endothelial cell of artery | 6 studies | 27% ± 9% | |
connective tissue cell | 5 studies | 31% ± 6% | |
effector CD8-positive, alpha-beta T cell | 4 studies | 18% ± 1% | |
vein endothelial cell | 4 studies | 24% ± 6% | |
effector memory CD8-positive, alpha-beta T cell | 4 studies | 21% ± 4% | |
gamma-delta T cell | 4 studies | 19% ± 3% | |
exhausted T cell | 3 studies | 25% ± 5% | |
capillary endothelial cell | 3 studies | 23% ± 4% | |
smooth muscle cell | 3 studies | 19% ± 4% | |
endothelial cell of sinusoid | 3 studies | 44% ± 24% | |
megakaryocyte | 3 studies | 63% ± 17% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 30% ± 4% |
Insufficient scRNA-seq data for expression of F2R at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 4192.43 | 577 / 578 | 95% | 43.57 | 1094 / 1155 |
breast | 93% | 1795.14 | 429 / 459 | 96% | 72.27 | 1074 / 1118 |
skin | 99% | 4500.57 | 1792 / 1809 | 88% | 143.35 | 417 / 472 |
thymus | 98% | 1860.66 | 642 / 653 | 88% | 43.31 | 535 / 605 |
intestine | 89% | 1246.74 | 855 / 966 | 91% | 42.16 | 479 / 527 |
kidney | 100% | 2462.87 | 89 / 89 | 75% | 70.70 | 673 / 901 |
adrenal gland | 97% | 2114.40 | 250 / 258 | 72% | 25.30 | 166 / 230 |
esophagus | 76% | 887.87 | 1099 / 1445 | 90% | 53.35 | 165 / 183 |
prostate | 83% | 1074.40 | 204 / 245 | 78% | 29.55 | 393 / 502 |
uterus | 88% | 1177.10 | 149 / 170 | 66% | 23.97 | 303 / 459 |
stomach | 59% | 540.40 | 213 / 359 | 93% | 55.38 | 266 / 286 |
bladder | 67% | 852.29 | 14 / 21 | 72% | 25.92 | 365 / 504 |
pancreas | 24% | 217.62 | 79 / 328 | 97% | 85.80 | 172 / 178 |
ovary | 36% | 350.40 | 64 / 180 | 68% | 20.89 | 293 / 430 |
liver | 52% | 522.86 | 118 / 226 | 49% | 15.38 | 197 / 406 |
spleen | 100% | 4977.49 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5951.13 | 1332 / 1335 | 0% | 0 | 0 / 0 |
brain | 2% | 15.55 | 52 / 2642 | 96% | 69.44 | 676 / 705 |
adipose | 95% | 2198.05 | 1149 / 1204 | 0% | 0 | 0 / 0 |
heart | 93% | 1902.16 | 805 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 76% | 29.17 | 34 / 45 |
lymph node | 0% | 0 | 0 / 0 | 62% | 22.41 | 18 / 29 |
peripheral blood | 39% | 505.28 | 366 / 929 | 0% | 0 | 0 / 0 |
muscle | 22% | 180.39 | 176 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.39 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007529 | Biological process | establishment of synaptic specificity at neuromuscular junction |
GO_0006919 | Biological process | activation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0006954 | Biological process | inflammatory response |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0002248 | Biological process | connective tissue replacement involved in inflammatory response wound healing |
GO_1900134 | Biological process | negative regulation of renin secretion into blood stream |
GO_0045907 | Biological process | positive regulation of vasoconstriction |
GO_0051930 | Biological process | regulation of sensory perception of pain |
GO_0099553 | Biological process | trans-synaptic signaling by endocannabinoid, modulating synaptic transmission |
GO_0070493 | Biological process | thrombin-activated receptor signaling pathway |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0051209 | Biological process | release of sequestered calcium ion into cytosol |
GO_0036145 | Biological process | dendritic cell homeostasis |
GO_0043280 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO_0048873 | Biological process | homeostasis of number of cells within a tissue |
GO_0030168 | Biological process | platelet activation |
GO_0030193 | Biological process | regulation of blood coagulation |
GO_0048167 | Biological process | regulation of synaptic plasticity |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0045987 | Biological process | positive regulation of smooth muscle contraction |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0032967 | Biological process | positive regulation of collagen biosynthetic process |
GO_0032651 | Biological process | regulation of interleukin-1 beta production |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0060155 | Biological process | platelet dense granule organization |
GO_0032757 | Biological process | positive regulation of interleukin-8 production |
GO_0030194 | Biological process | positive regulation of blood coagulation |
GO_0009653 | Biological process | anatomical structure morphogenesis |
GO_0051928 | Biological process | positive regulation of calcium ion transport |
GO_0051281 | Biological process | positive regulation of release of sequestered calcium ion into cytosol |
GO_0003105 | Biological process | negative regulation of glomerular filtration |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0035025 | Biological process | positive regulation of Rho protein signal transduction |
GO_0043524 | Biological process | negative regulation of neuron apoptotic process |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0009611 | Biological process | response to wounding |
GO_0046427 | Biological process | positive regulation of receptor signaling pathway via JAK-STAT |
GO_0045217 | Biological process | cell-cell junction maintenance |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0007205 | Biological process | protein kinase C-activating G protein-coupled receptor signaling pathway |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0031594 | Cellular component | neuromuscular junction |
GO_0005769 | Cellular component | early endosome |
GO_0031094 | Cellular component | platelet dense tubular network |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0009986 | Cellular component | cell surface |
GO_0005770 | Cellular component | late endosome |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0005901 | Cellular component | caveola |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0031681 | Molecular function | G-protein beta-subunit binding |
GO_0001965 | Molecular function | G-protein alpha-subunit binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0015057 | Molecular function | thrombin-activated receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | F2R |
Protein name | Proteinase-activated receptor 1 (PAR-1) (Coagulation factor II receptor) (Thrombin receptor) Coagulation factor II (Thrombin) receptor, isoform CRA_b (Coagulation factor II thrombin receptor) |
Synonyms | PAR1 CF2R TR hCG_37484 |
Description | FUNCTION: High affinity receptor for activated thrombin coupled to G proteins that stimulate phosphoinositide hydrolysis. May play a role in platelets activation and in vascular development. . |
Accessions | ENST00000319211.5 P25116 G3XAL6 ENST00000505600.1 |